Identification | Back Directory | [Name]
(S)-N,N-DIMETHYL-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLAMINE | [CAS]
55650-58-3 | [Synonyms]
(S)-(R)-PPFA Josiphos SL-0000-1 (S)-(+)-N,N-DIMETHYL-1-(2-DIPHENYLP (+)-(S)-N,N-dimethyl-1-((R)-2-(diphenyl-phosphino (S,R)-1-(1-dimethylaminoethyl)-2-*(diphenylphosph (+)-(S)-N,N-dimethyl-1-((R)-2-(diphenyl-phosphino (S)-(+)-N,N-DiMethyl-1-(2-diphenylphosphino)ferrocenylethyla (+)-(S)-N,N-DIMETHYL-1-[(R)-2(DIPHENYLPHOSPHINO)FERROCENYL]ETHYL 1(S)-[1(R)-(DIMETHYLAMINO)ETHYL]-2-(DIPHENYL-PHOSPHANY)FERROCENE (S)-(+)-N,N-DIMETHYL-1-(2-DIPHENYLPHOSPHINO)FERROCENYLETHYLAMINE (S)-N,N-DIMETHYL-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLAMINE (S)-N,N-DIMETHYL-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLAMNIE (2R)-1-[(1S)-1-(dimethylamino)ethyl]-2-(diphenylphosphino)-Ferrocene (+)-(S)-N,N-DIMETHYL-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLAMINE Ferrocene, 1-[(1S)-1-(dimethylamino)ethyl]-2-(diphenylphosphino)-,(2R)- FERROCENE, 1-[1-(DIMETHYLAMINO)ETHYL]-2-(DIPHENYL-PHOSPHINO)-, [R-(R*S*)]- (2R)-1-[(1S)-1-(Dimethylamino)ethyl]-2-(diphenylphosphino)ferrocene,99%e.e. | [EINECS(EC#)]
678-897-9 | [Molecular Formula]
C26H28FeNP 10* | [MDL Number]
MFCD00075285 | [MOL File]
55650-58-3.mol | [Molecular Weight]
441.33 |
Chemical Properties | Back Directory | [Melting point ]
141-143°C | [alpha ]
355 º (C=0.6 IN ETOH) | [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [form ]
solid | [color ]
Light yellow to Brown | [Water Solubility ]
Insoluble in water. | [Sensitive ]
Air Sensitive |
Safety Data | Back Directory | [Hazard Codes ]
Xi,Xn | [Safety Statements ]
22-26-36/37/39-36 | [RIDADR ]
3288 | [Hazard Note ]
Irritant/Air Sensitive | [HazardClass ]
6.1 | [PackingGroup ]
III | [HS Code ]
2931499090 | [Risk Statements ]
HD不仅对精神分裂症有较好地防复发作用,对一些难治的情感性精神病也有防复发效能。HD合并锂盐治疗躁狂症比单用锂盐或氯氮平更能减少或预防复发。另外,HD能很好地消除分裂情感性精神病(SAP)患者的情感症状。由此看出,HD是一种很好的精神病维持治疗药物。
图2:葵酸氟哌啶醇注射液
|
Hazard Information | Back Directory | [Uses]
(S)-(+)-N,N-Dimethyl-1-[(R)-2-(diphenylphosphino)ferrocenyl]ethylamine is the raw material of asymmetric hydrogenation chiral ligands. |
|
|